Publications by authors named "Assaf Moore"

Claim this Profile
B
BRAF inhibitor or BRAF/MEK inhibitor treatment for patients with metastatic BRAF V600E mutated differentiated thyroid cancer.
Inbar Finkel, Yasmin Korzets, Assaf Moore, Tara Coreanu, Aron Popovtzer

Arch Endocrinol Metab· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic Radiotherapy to the Prostate and Pelvic Lymph Nodes for High-Risk and Very High-Risk Prostate Cancer in a Setting with a Hydrogel Spacer: A Toxicity Report.
Elisha Fredman, Roi Tschernichovsky, Danielle Shemesh, Miriam Weinstock-Sabbah, Ruth Dadush Azuz, Assaf Moore

Cancers (Basel)· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing-Initial Report of the SABR-Dual Trial.
Elisha Fredman, Assaf Moore, Oded Icht, Roi Tschernichovsky, Danielle Shemesh

Int J Radiat Oncol Biol Phys· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term Outcomes from a Phase 1 Dose Escalation Study Using Stereotactic Body Radiotherapy for Patients with Low- or Intermediate-risk Prostate Cancer.
Assaf Moore, Marisa A Kollmeier, Sean M McBride, Nicolas Toumbacaris, Zhigang Zhang

Eur Urol Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
40 Gray in 5 Fractions for Salvage Reirradiation of Spine Lesions Previously Treated With Stereotactic Body Radiotherapy.
Assaf Moore, Zhigang Zhang, Teng Fei, Lei Zhang, Laura Accomando

Neurosurgery· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time.
Itamar Averbuch, Assaf Moore, Ethan B Ludmir, Gal Markel, Tomer Meirson

Br J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy.
Oded Icht, Shir Schlosser, Miriam Weinstock-Sabbah, Mor Rephael, Dimitri Bragilovski, Assaf Moore

Front Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of radiotherapy for the treatment of laryngeal squamous cell carcinoma in the very elderly population.
Orly Yariv, Nimrod Amitai, Yuval Nachalon, Assaf Moore, Aron Popovtzer

J Laryngol Otol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Radiological Tumor Thickness on Prognosis of Early Glottic-Squamous Cell Carcinoma Treated With Radiation.
Or Dagan, Alain Perlow, Hagit Shoffel-Havakuk, Ameen Biadsee, Assaf Moore

J Voice· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer.
Elisha Fredman, Oded Icht, Assaf Moore, Dimitri Bragilovski, Jonathan Kindler

BMC Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy.
Elisha Fredman, Miriam Weinstock-Sabbah, Oded Icht, Assaf Moore, Tzippora Shochet

Front Oncol· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Local Failure after Prostate SBRT Predominantly Occurs in the PI-RADS 4 or 5 Dominant Intraprostatic Lesion.
Daniel Gorovets, Andreas G Wibmer, Assaf Moore, Stephanie Lobaugh, Zhigang Zhang

Eur Urol Oncol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer.
Assaf Moore, Stephanie M Lobaugh, Zhigang Zhang, Jonathan E Rosenberg, Gopa Iyer

Bladder Cancer· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of gastric fundus radiation dose on postoperative anastomotic leakage in esophageal cancer.
Yulia Kundel, Noga Kurman, Omri Sulimani, Shlomo Gavrielli, Yuval Nachalon, Assaf Moore

Front Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-line programmed death-1 inhibitor treatment for locoregionally advanced or metastatic cutaneous squamous cell carcinoma - A real-world experience from Israel.
Itamar Averbuch, Saeed Salman, Noa Shtamper, Ilana Doweck, Aron Popovtzer, Assaf Moore

Front Oncol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health Disparities in Prostate Cancer and Approaches to Advance Equitable Care.
Cyrus Washington, Daniel A Goldstein, Assaf Moore, Ulysses Gardner, Curtiland Deville

Am Soc Clin Oncol Educ Book· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic impact of HER2-low expression in hormone receptor positive early breast cancer.
Raz Mutai, Tamar Barkan, Assaf Moore, Michal Sarfaty, Tzippy Shochat

Breast· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early outcomes of high-dose-rate brachytherapy combined with ultra-hypofractionated radiation in higher-risk prostate cancer.
Daniel Gorovets, Margaret Hopkins, Marisa Kollmeier, Assaf Moore, Arun Goel

Brachytherapy· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Exogenous Estrogen Exposure on the Characteristics and Outcome of Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early-Stage Breast Cancer.
Orly Yariv, Raz Mutai, Ofer Rotem, Daliah Tsoref, Yasmin Korzets, Assaf Moore

Oncology· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Cost of Enfortumab Vedotin Wastage Due to Vial Size-A Real-World Analysis.
Michal Sarfaty, Assaf Moore, Ashley M Regazzi, Aaron P Mitchell, Jonathan E Rosenberg

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis.
Daniel Reinhorn, Raz Mutai, Rinat Yerushalmi, Assaf Moore, Eitan Amir

Breast· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
Assaf Moore, Shlomit Yust-Katz, Oded Icht, Ruth Eliyahou, Noa Gordon

J Neurol Sci· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancer.
Yasmin Korzets, Orly Yariv, Raz Mutai, Assaf Moore, Tzippy Shochat

Discov Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of Continuous Positive Airway Pressure (CPAP) to Limit Diaphragm Motion-A Novel Approach for Definitive Radiation Therapy for Inoperable Pleural Mesothelioma: A Pilot Study.
Assaf Moore, Marc J Kindler, Aaron Max Allen

Biology (Basel)· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing in thyroid cancers: do targetable alterations lead to a therapeutic advantage?: A multicenter experience.
Assaf Moore, Yael Bar, Corinne Maurice-Dror, Inbar Finkel, Hadar Goldvaser

Medicine (Baltimore)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis